Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
VECT.US
id: 755

VectivBio Holding AG (VECT) Case on Misleading

S.D. New York
Court
1:23-cv-04833
Case number
06 Aug 2023
Lead Plaintiff motion deadline
  • Ironwood to acquire VectivBio for $17.00 per share in an all-cash.
  • Investors suspect VectivBio misrepresented its financial projections.
On May 22, 2023, Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) and VectivBio Holding AG (Nasdaq: VECT) announced that they entered into a definitive agreement for Ironwood to acquire VectivBio for $17.00 per share in an all-cash transaction with an estimated aggregate consideration of approximately $1 billion, net of VectivBio cash and debt.

Taking all representations into account, VectiveBio shareholders have reasons to suspect that the Company of misrepresenting VectivBio's financial projections.
Case Status
Lead Plaintiff Appointed
Alleged Offence
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
22 May 2023
Filing date
06 June 2023
Lead Plaintiff Deadline
06 August 2023
Collecting participants…

VectivBio Holding AG

VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apr...

    Ticker
    VECT.US
    ISIN
    CH1109007893
    CIK
    1836379
    Sector
    Healthcare
    Industry
    Pharmaceuticals
    Country
    USA
    Address
    Aeschenvorstadt 36, Basel, Switzerland, 4051